Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Polycystic Kidney Disease: early-phase trial registry
5 of 6 indexed Polycystic Kidney Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Polycystic Kidney Disease: 6 US clinical trials tracked, 5 recruiting.
Polycystic Kidney Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Alan Yu, MB, BChir, running 1 of these trials.
Enrollment posture brief
Registry condition polycystic-kidney-disease
OPEN 5 | RECR 83% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Polycystic Kidney Disease lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Polycystic Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Polycystic Kidney Disease is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Polycystic Kidney Disease research.
Alan Yu, MB, BChir accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Polycystic Kidney Disease enrolment sits around 250 participants.
Median target enrolment is 250 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Polycystic Kidney Disease splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Polycystic Kidney Disease Data Repository
The Rogosin Institute
NCT00792155
PKD Clinical and Translational Core Study
University of Maryland, Baltimore
NCT01873235
Early PKD Observational Cohort Study
University of Kansas Medical Center
NCT02936791
Amnioinfusion for Fetal Renal Failure
Fetal Care Center, P
NCT06728228
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
Ohio State University
NCT06325644
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Alan Yu, MB, BChir
NCT02140814
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Polycystic Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Polycystic Kidney Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Polycystic Kidney Disease page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Polycystic Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Alan Yu, MB, BChir sponsors the most Polycystic Kidney Disease trials on record, review their full trial history before evaluating a specific study. See Alan Yu, MB, BChir's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polycystic Kidney Disease condition card totals 6 registered trials; most-linked intervention Niacinamide; top US site state Kansas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.